Other equities analysts have also issued reports about the stock. Deutsche Bank AG restated a “buy” rating and issued a $97.00 price objective on shares of Danaher Corporation in a report on Wednesday, June 21st. Credit Suisse Group reaffirmed a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a research note on Wednesday, May 24th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $96.00 target price on the stock in a research note on Tuesday, April 4th. BTIG Research reaffirmed a “buy” rating and set a $92.00 target price on shares of Danaher Corporation in a research note on Sunday, April 23rd. Finally, Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $91.76.
Danaher Corporation (NYSE:DHR) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday, July 8th.
Danaher Corporation (NYSE:DHR) traded up 0.57% during mid-day trading on Friday, reaching $81.28. The company’s stock had a trading volume of 4,393,258 shares. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The company has a 50-day moving average price of $83.93 and a 200-day moving average price of $84.29. The firm has a market cap of $56.46 billion, a PE ratio of 25.94 and a beta of 1.04.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same period in the prior year, the business posted $0.90 EPS. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current year.
In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the completion of the sale, the senior vice president now owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders sold a total of 38,623 shares of company stock valued at $3,206,426 in the last 90 days. Company insiders own 12.20% of the company’s stock.
Several hedge funds have recently made changes to their positions in DHR. GLG LLC bought a new stake in shares of Danaher Corporation during the fourth quarter valued at approximately $2,685,000. Tudor Investment Corp Et Al boosted its stake in shares of Danaher Corporation by 643.7% in the fourth quarter. Tudor Investment Corp Et Al now owns 484,432 shares of the conglomerate’s stock valued at $37,708,000 after buying an additional 419,292 shares during the period. Seven Eight Capital LP bought a new stake in shares of Danaher Corporation during the fourth quarter valued at approximately $2,150,000. Ancora Advisors LLC bought a new stake in shares of Danaher Corporation during the fourth quarter valued at approximately $386,000. Finally, Guggenheim Capital LLC boosted its stake in shares of Danaher Corporation by 16.1% in the fourth quarter. Guggenheim Capital LLC now owns 858,913 shares of the conglomerate’s stock valued at $66,859,000 after buying an additional 118,853 shares during the period. Hedge funds and other institutional investors own 76.22% of the company’s stock.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.